AKTS
Price
$16.37Alerts
Change
+$0.55 (+3.48%)
Updated
Nov 9 closing price
Capitalization
879.9M
2 days until earnings call
Intraday BUY SELL Signals
ZBRA
Price
$326.71Alerts
Change
+$4.69 (+1.46%)
Updated
Nov 9 closing price
Capitalization
15.23B
100 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AKTS vs ZBRA

AKTS vs ZBRA Comparison Chart in %
View a ticker or compare two or three
VS
AKTS vs. ZBRA commentary
Nov 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKTS is a Buy and ZBRA is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AKTS with price predictions
Nov 09, 2026

AKTS sees its Stochastic Oscillator ascending out of oversold territory

On November 05, 2026, the Stochastic Oscillator for AKTS moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 50 instances where the indicator left the oversold zone. In 44 of the 50 cases the stock moved higher in the following days. This puts the odds of a move higher at over 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AKTS's RSI Indicator exited the oversold zone, 23 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on AKTS as a result. In 53 of 65 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

The Moving Average Convergence Divergence (MACD) for AKTS just turned positive on October 21, 2026. Looking at past instances where AKTS's MACD turned positive, the stock continued to rise in 24 of 31 cases over the following month. The odds of a continued upward trend are 77%.

Following a +10.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where AKTS advanced for three days, in 172 of 204 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

AKTS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 50-day moving average for AKTS moved below the 200-day moving average on October 27, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AKTS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for AKTS entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.815) is normal, around the industry mean (3.498). P/E Ratio (-11.965) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (125.000) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. AKTS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 70 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AKTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for ZBRA with price predictions
Nov 09, 2026

ZBRA in -8.79% downward trend, sliding for three consecutive days on November 03, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ZBRA declined for three days, in 221 of 305 cases, the price declined further within the following month. The odds of a continued downward trend are 72%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ZBRA as a result. In 61 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.

The Moving Average Convergence Divergence Histogram (MACD) for ZBRA turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 30 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.

ZBRA moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ZBRA crossed bearishly below the 50-day moving average on November 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 40%.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZBRA advanced for three days, in 204 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

ZBRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 105 of 158 cases where ZBRA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating steady price growth. ZBRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.435) is normal, around the industry mean (5.210). P/E Ratio (29.275) is within average values for comparable stocks, (3.688). Projected Growth (PEG Ratio) (0.626) is also within normal values, averaging (0.778). Dividend Yield (0.000) settles around the average of (0.067) among similar stocks. P/S Ratio (2.910) is also within normal values, averaging (11.937).

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZBRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.

FUNDAMENTALS RATINGS
AKTS vs ZBRA: Fundamental Ratings
AKTS
ZBRA
OUTLOOK RATING
1..100
1559
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
65
Fair valued
PROFIT vs RISK RATING
1..100
70100
SMR RATING
1..100
9455
PRICE GROWTH RATING
1..100
3454
P/E GROWTH RATING
1..100
1431
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AKTS's Valuation (14) in the Telecommunications Equipment industry is somewhat better than the same rating for ZBRA (65) in the Computer Peripherals industry. This means that AKTS’s stock grew somewhat faster than ZBRA’s over the last 12 months.

AKTS's Profit vs Risk Rating (70) in the Telecommunications Equipment industry is in the same range as ZBRA (100) in the Computer Peripherals industry. This means that AKTS’s stock grew similarly to ZBRA’s over the last 12 months.

ZBRA's SMR Rating (55) in the Computer Peripherals industry is somewhat better than the same rating for AKTS (94) in the Telecommunications Equipment industry. This means that ZBRA’s stock grew somewhat faster than AKTS’s over the last 12 months.

AKTS's Price Growth Rating (34) in the Telecommunications Equipment industry is in the same range as ZBRA (54) in the Computer Peripherals industry. This means that AKTS’s stock grew similarly to ZBRA’s over the last 12 months.

AKTS's P/E Growth Rating (14) in the Telecommunications Equipment industry is in the same range as ZBRA (31) in the Computer Peripherals industry. This means that AKTS’s stock grew similarly to ZBRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AKTSZBRA
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
68%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
70%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
66%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 8 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
67%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
66%
COMPARISON
Comparison
Nov 10, 2026
Stock price -- (AKTS: $16.37 vs. ZBRA: $326.71)
Brand notoriety: AKTS and ZBRA are both not notable
AKTS represents the Biotechnology, while ZBRA is part of the Telecommunications Equipment industry
Current volume relative to the 65-day Moving Average: AKTS: 122% vs. ZBRA: 182%
Market capitalization -- AKTS: $879.9M vs. ZBRA: $15.23B
AKTS [@Biotechnology] is valued at $879.9M. ZBRA’s [@Telecommunications Equipment] market capitalization is $15.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The market cap for tickers in the [@Telecommunications Equipment] industry ranges from $3.88K to $370.01B. The average market capitalization across the [@Biotechnology] industry is $2.23B. The average market capitalization across the [@Telecommunications Equipment] industry is $16.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKTS’s FA Score shows that 2 FA rating(s) are green while ZBRA’s FA Score has 1 green FA rating(s).

  • AKTS’s FA Score: 2 green, 3 red.
  • ZBRA’s FA Score: 1 green, 4 red.
According to our system of comparison, AKTS is a better buy in the long-term than ZBRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKTS’s TA Score shows that 6 TA indicator(s) are bullish while ZBRA’s TA Score has 5 bullish TA indicator(s).

  • AKTS’s TA Score: 6 bullish, 3 bearish.
  • ZBRA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AKTS is a better buy in the short-term than ZBRA.

Price Growth

AKTS (@Biotechnology) experienced а +12.20% price change this week, while ZBRA (@Telecommunications Equipment) price change was -9.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.23%. For the same industry, the average monthly price growth was -8.97%, and the average quarterly price growth was +85.13%.

The average weekly price growth across all stocks in the @Telecommunications Equipment industry was -2.55%. For the same industry, the average monthly price growth was -13.52%, and the average quarterly price growth was -21.51%.

Reported Earning Dates

AKTS is expected to report earnings on Nov 12, 2026.

ZBRA is expected to report earnings on Feb 18, 2027.

Industries' Descriptions

@Biotechnology (+2.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Telecommunications Equipment (-2.55% weekly)

The Telecommunications Equipment industry produces voice and data communications equipment, which includes fiber optic delivery products, digital signal processors, high-speed voice, data and video delivery. Additionally, satellite systems, global positioning systems, wireless data systems, personal communications equipment, telephone handsets and payload equipment for satellites also fall into this category. Apple Inc., QUALCOMM Incorporated and Nokia are major global players in this segment.

View a ticker or compare two or three
Interact to see
Advertisement

AKTS and

Correlation & Price change

A.I.dvisor tells us that AKTS and SPRY have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKTS and SPRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKTS
1D Price
Change %
AKTS100%
+3.48%
SPRY - AKTS
29%
Poorly correlated
+12.90%
CRDO - AKTS
24%
Poorly correlated
+10.27%
KN - AKTS
24%
Poorly correlated
+5.63%
LITE - AKTS
24%
Poorly correlated
+10.69%
ZBRA - AKTS
23%
Poorly correlated
+1.46%
More

ZBRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZBRA has been loosely correlated with PI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ZBRA jumps, then PI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZBRA
1D Price
Change %
ZBRA100%
+1.46%
PI - ZBRA
44%
Loosely correlated
+2.16%
ITRN - ZBRA
43%
Loosely correlated
+4.14%
KN - ZBRA
38%
Loosely correlated
+5.63%
TSAT - ZBRA
34%
Loosely correlated
+8.40%
HLIT - ZBRA
32%
Poorly correlated
+7.57%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USLM120.232.13
+1.80%
United States Lime & Minerals
EIX60.140.77
+1.30%
Edison International
TIGR3.950.05
+1.28%
UP Fintech Holding Ltd
SMID26.160.05
+0.19%
Smith-Midland Corp
SFHG1.95-0.04
-2.01%
Samfine Creation Holdings Group Ltd